Llwytho...

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

BACKGROUND: Bevacizumab and the antimetabolites capecitabine and gemcitabine have been shown to improve outcomes when added to taxanes in patients with metastatic breast cancer. The primary aims of this trial were to determine whether the addition of capecitabine or gemcitabine to neoadjuvant chemot...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Bear, Harry D., Tang, Gong, Rastogi, Priya, Geyer, Charles E., Robidoux, André, Atkins, James N., Baez-Diaz, Luis, Brufsky, Adam M., Mehta, Rita S., Fehrenbacher, Louis, Young, James A., Senecal, Francis M., Gaur, Rakesh, Margolese, Richard G., Adams, Paul T., Gross, Howard M., Costantino, Joseph P., Swain, Sandra M., Mamounas, Eleftherios P., Wolmark, Norman
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3401076/
https://ncbi.nlm.nih.gov/pubmed/22276821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1111097
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!